Halozyme Therapeutics shares owned by Lombard Odier Asset Management
Quarter-by-quarter ownership of Halozyme Therapeutics (HALO) shares owned by Lombard Odier Asset Management
from 13F filings
Historical chart of Lombard Odier Asset Management investment in Halozyme Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Halozyme Therapeutics held by Lombard Odier Asset Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Halozyme Therapeutics by Lombard Odier Asset Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-03-31 | $9.2M | 144k | 63.81 |
| 2024-12-31 | $7.8M | 164k | 47.81 |
| 2024-09-30 | $7.2M | 125k | 57.24 |
| 2024-06-30 | $11M | 200k | 52.36 |
| 2023-03-31 | $382k | 10k | 38.19 |
| 2022-12-31 | $1.1M | 20k | 56.90 |
| 2022-09-30 | $791k | 20k | 39.55 |
| 2022-06-30 | $880k | 20k | 44.00 |
More positions owned by Lombard Odier Asset Management
View all positions for Lombard Odier Asset Management